Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904436 · ClinicalTrials.gov registry record · NA
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
A NA study of Tetraplegia and Dyspnea, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00904436: Completed NA study of Tetraplegia and Dyspnea, sponsored by US Department of Veterans Affairs.
NCT00904436 is a NA study of Tetraplegia and Dyspnea that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 20 participants, above the 18-participant average among 23 other Tetraplegia trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904436, a NA study of Tetraplegia and Dyspnea, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Breathlessness is an extremely common and uncomfortable symptom that is reported in more than two-thirds of persons with tetraplegia. This disordered pulmonary function is due to respiratory muscle paralysis or to sympathetic denervation results in a restrictive impairment and airway hyperreactivity, respectively. These restrictive and obstructive dysfunctions have been associated with the symptom of breathlessness. However, mechanisms contributing to dyspnea in persons who have tetraplegia are not well understood. It has been demonstrated that persons with tetraplegia have an increased prevalence of breathlessness and may have an altered breathing pattern. The purpose of this study is to determine the breathing pattern at rest and measure the changes in breathing after a bronchodilator treatment (a medicine commonly used to treat asthma that relaxes and opens up airways). The determination of breathing pattern is done by measuring the movements in the chest wall while breathing. This design will elucidate differences in breathing patterns between those with tetraplegia and controls, as well as demonstrate the effect of bronchodilatation on motor drive and timing. Knowledge of the intraindividual variability and mean values of the components of the breathing pattern will improve our understanding of breathlessness in these individuals.
Conditions Studied
Interventions
- DRUG ipratropium (Atrovent)
Study Locations (1)
New York
- VA Medical Center, Bronx - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1999-12 |
| Est. Completion | 2001-01 |
| Phase | NA |
What the finished NCT00904436 record still lists
NCT00904436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, above the 18-participant average among 23 other Tetraplegia trials with a reported enrollment target (11% higher).
The record links to 2 conditions, with Tetraplegia appearing as the primary indexed condition, and to 1 intervention - of which ipratropium (Atrovent) is the first listed.
NCT00904436 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00904436 about?
NCT00904436 is a clinical study titled "Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia". Breathlessness is an extremely common and uncomfortable symptom that is reported in more than two-thirds of persons with tetraplegia. This disordered pulmonary function is due to respiratory muscle paralysis or to sympathetic denervation results in a restrictive impairment and airway hyperreactivity...
What is the current status of trial NCT00904436?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 1999-12. Estimated completion is 2001-01.
What conditions does trial NCT00904436 study?
This clinical trial studies the following conditions: Tetraplegia, Dyspnea.
What interventions are being tested in trial NCT00904436?
The interventions under investigation include: ipratropium (Atrovent) (DRUG).
Who is sponsoring clinical trial NCT00904436?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00904436 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetraplegia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00904436's enrollment target sits among peer trials
20 10th of 23 higher than 14 of 23 other Tetraplegia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tetraplegia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Evaluation of an Advanced Lower Extremity Neuroprostheses
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
Investigation on the Cortical Communication (CortiCom) System
RECRUITING · NA
-
A Neuroprosthesis for Seated Posture and Balance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia